Eli Lilly stock continues to move higher after the company reported continuing momentum for its flagship GLP-1 weight loss drugs
Eli Lilly Gains on the GLP-1 Weight Loss Phenomenon
Read Also
- Analysts race to revamp Nvidia price targets ahead of earnings
- Low-pressure area over Bay in next two days, may strengthen monsoon
- What's New In Consumer Tech World Last Week? News That You Should Know (May 12-May 19, 2024)
- Disney's Latest Unionization Cast Vote Could Signal Shifts in Operational Costs and Investor Outlook
- Chinese EV Maker Li Auto Misses Q1 Revenue Expectations Despite Surging Vehicle Sales, Stock Tanks
- Why Is EHang Holdings Stock Rising Premarket Monday?
- Japanese companies Hitachi, Kawasaki vying for India’s bullet train sets
- Insiders Buying Sempra And 2 Other Stocks
- Indian cocoa market steady amidst volatile international price movements
- Understanding IRS Form 1096
Latest MarketBeat
- MarketBeat Week in Review – 5/13 - 5/17
- Take-Two Interactive Software Offers 2nd Chance for Investors
- Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook
- Analysts Still Want Double-Digit Upside Out of Applied Materials
- Baidu Stock Earnings Prove Ray Dalio Right about China?
- 3 Reasons Nvidia is on The Verge of a 4 Digit Stock Price
- Bargain Alert: Lululemon Shares Could Be About To Hit Rally Mode
- Bears Sent a False Alarm for Under Armour Stock
- Gamestop is Heading Back to $10 or Lower
- Squarespace’s Buyout Signals a Recovering Financial Market